#SFHS2605824VNotice on Pharmaceutical Specialty Prices under Article L. 162-16-5 of the Social Security Code
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This regulation sets the price for a specific pharmaceutical product sold to healthcare institutions. It affects healthcare providers that purchase medications from BIOGARAN. They must now adhere to the established price for the Raltegravir BGA 600MG tablet.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Price set for Raltegravir BGA 600MG tablet
- Establishments must comply with new pricing
- BIOGARAN involved with supply
Obligations
What this law requires
Healthcare institutions must purchase Raltegravir BGA 600MG tablets from BIOGARAN at the established price of €3.839 per unit (excluding taxes)
Healthcare institutions must apply the ex-tax selling price (HT) of €3.839 per UCD unit when purchasing the pharmaceutical specialty referenced by UCD code 34008900428 8 8
BIOGARAN must maintain the agreed-upon price of €3.839 HT per unit for Raltegravir BGA 600MG tablets in transactions with healthcare institutions, as established under the economic convention with the health products economic committee